Utilization, safety and tolerability of ocrelizumab: Year 1 Data from the Providence Ocreclizumab Registry

Authors

• Kyle E Smoot, Providence Multiple Sclerosis Center, Providence Health & Services, 9427 SW Barnes Road, Portland, OR 97225, USA; Providence Brain and Spine Institute, Providence Health & Services, 9135 SW Barnes Road, Suite 461, Portland, OR 97225, USAFollow
• Chiayi Chen, Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, USAFollow
• tamela stuchiner, Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, Providence Health & Services, Portland, OR, USAFollow
• Lois Grote, Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, Providence Health & Services, Portland, OR, USAFollow
• Lindsay Lucas, Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, USAFollow
• Stanley Cohan, Providence Multiple Sclerosis Center, USA.Follow

Document Type

Presentation

Publication Date

2018

Keywords

oregon; providence neuroscience institute

Area of Special Interest

Neurosciences (Brain & Spine)

Specialty/Research Institute

Neurosciences